Keli Hippen, PhD
Associate Professor, Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, USA
Dr. Hippen received his PhD in Molecular, Cellular & Developmental Biology from Iowa State University, Ames, IA (USA) in 1993. He did postdoctoral work in the labs of John Cambier (National Jewish Center for Immunology and Respiratory Medicine, Denver, CO, USA) and Timothy Behrens (Division of Rheumatology, Department of Medicine, University of Minnesota, Minneapolis, MN, USA), before joining the faculty at the University of Minnesota in 2001.
Dr. Hippen’s main research area is to develop and support human adoptive cell therapy clinical trials. He has been involved in 3 'first in human' clinical trials using regulatory T cells (Treg) to suppress GVHD following transplantation, and is currently developing Treg expansion protocols to treat autoimmunity and transplant rejection. In addition, Dr. Hippen is developing clinical protocols for the purification and in vitro expansion of tumor killing cells (e.g. chimeric antigen receptor T cells and NK cells).He has peer reviewed publications for many immunology-related and translational journals, such as: Journal of Immunology, European Journal of Immunology, Blood, Transplantation, Biology of Blood and Marrow Transplantation and Cytotherapy.